Medical groups mounted a new legal bid Monday to break a US pharma giant's hold on a hepatitis C drug whose price—costing thousands of dollars for a typical course—has unleashed a fierce patent battle.
Mar 27, 2017
0
8
A medical charity scored a small victory Wednesday in its bid to break a US pharma giant's hold on an eye-wateringly expensive Hepatitis C drug when a European body partially revoked the firm's patent.
Oct 5, 2016
0
0
A rapid HIV diagnostic kit for developing nations, designed by Cambridge University researcher Helen Lee, won the Popular Prize at the European Inventor Awards on Thursday.
Jun 9, 2016
0
53
French charity Medecins du Monde (MdM) on Tuesday said it was contesting a European patent awarded to a hepatitis drug made by US firm Gilead Sciences, arguing the treatment was too costly.
Feb 10, 2015
0
7
A new substance class for the treatment of multiple sclerosis and other neurodegenerative diseases now promises increased efficacy paired with fewer side effects.
Nov 26, 2012
0
0
For centuries, Indian housewives have used homemade remedies based on cow's milk to cure constipation—but in 2009 Swiss giant Nestle applied for a patent to protect a similar product of its own.
Oct 14, 2012
0
0
